Age-related factors : Many patients prescribed GLP-1 medications are middle-aged or older, demographics where benign prostatic hyperplasia (in men) and overactive bladder syndrome (in both sexes) become more prevalent
However, future prospective randomized, controlled trials are needed to explore the role of natural bioactive compounds as well as their supplements on health status, lung function and risk of COPD development
Any instance where an AI model interprets data must still result in human-reviewed actions or overrides, unless the system itself is validated as a computerized control
We've worked with researchers who saw no response at 300mcg daily but achieved statistically significant results at 500mcg twice daily, highlighting the importance of both dose magnitude and dosing frequency in experimental design
The claim of seeing results in just 7 days is also highly doubtful and lacks clinical evidence
[2] "The effects of GLP-1 medications taken when women become pregnant are unknown, says Dr